Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP626469.RArn5NCY-F_9cRmdi3nLccYNjaZggyHqznfnfJqr2g5-M130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626469.RArn5NCY-F_9cRmdi3nLccYNjaZggyHqznfnfJqr2g5-M130_provenance.
• NP746647.RAir2rTu4v52oieohxese2_cfAzq0IXJmxEVLs6MshBKA130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746647.RAir2rTu4v52oieohxese2_cfAzq0IXJmxEVLs6MshBKA130_provenance.
• NP275283.RAiyDqloEjYiTEoiLaPVM5DOsZrX73lisjRBXFFznnDPs130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275283.RAiyDqloEjYiTEoiLaPVM5DOsZrX73lisjRBXFFznnDPs130_provenance.
• NP369452.RARkTic79tifufiZIDa-ywcHJWpbl87uhULM9XWB2Kc8Y130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369452.RARkTic79tifufiZIDa-ywcHJWpbl87uhULM9XWB2Kc8Y130_provenance.
• NP387360.RA-IjsUlFyuHJGC83yGvipikpsWDB8WMDABUheQGgPRac130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387360.RA-IjsUlFyuHJGC83yGvipikpsWDB8WMDABUheQGgPRac130_provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP247288.RATDd0y114ddncvW_Aoj46IF3tumy9OkoIW2WM4qWznQc130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247288.RATDd0y114ddncvW_Aoj46IF3tumy9OkoIW2WM4qWznQc130_provenance.
• NP247297.RAWrY1XVNQR7G0Blk20WYxKfcurBLcq1iaMe5aovTZ8Og130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247297.RAWrY1XVNQR7G0Blk20WYxKfcurBLcq1iaMe5aovTZ8Og130_provenance.
• NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856158.RArUSo1R4eAwRBEO7PlUsJpE-wplv_tddfsVHC4FHc8_c130_provenance.
• NP676353.RAGB0LdQQbBBdGL0pPnk7nWfPCIzKDOHl9l2KnWl9mVwI130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676353.RAGB0LdQQbBBdGL0pPnk7nWfPCIzKDOHl9l2KnWl9mVwI130_provenance.
• NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.
• NP305739.RA7UWg6oaWszr2-5JB5MxmaH982Fi-Fb0EzOMBGr4DY90130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305739.RA7UWg6oaWszr2-5JB5MxmaH982Fi-Fb0EzOMBGr4DY90130_provenance.
• NP306221.RA2e8dhEOSuYc1et7weOofbEz7egaeEQCJXAYV0fSa-5o130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306221.RA2e8dhEOSuYc1et7weOofbEz7egaeEQCJXAYV0fSa-5o130_provenance.
• NP307512.RAKBz9lIjerUmL0EXCC892Tos0SreKsJZ2mQe9F7aL3xs130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307512.RAKBz9lIjerUmL0EXCC892Tos0SreKsJZ2mQe9F7aL3xs130_provenance.
• NP752528.RAHS1GLGwJubhb0rBC8AWvH-03DS4e7JWre_fa7KImVdc130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752528.RAHS1GLGwJubhb0rBC8AWvH-03DS4e7JWre_fa7KImVdc130_provenance.
• NP847704.RAHBZym5rAwNk4N-ynzKFpF3jlJczCDN5ubuy2lyV2aFc130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847704.RAHBZym5rAwNk4N-ynzKFpF3jlJczCDN5ubuy2lyV2aFc130_provenance.
• NP247294.RAP6TKVvkjm4OczEI7TLClIdNov1CX95wWdEbAcVgorcU130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247294.RAP6TKVvkjm4OczEI7TLClIdNov1CX95wWdEbAcVgorcU130_provenance.
• NP247298.RAH4f76E7_SJGRiIvqN04IImQmzBvGQoRQHP81WbXdyBc130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247298.RAH4f76E7_SJGRiIvqN04IImQmzBvGQoRQHP81WbXdyBc130_provenance.
• NP893256.RA-k1Elz2lt0362TUiAaa09svgmBaQcYDgWV3RXei-Ayk130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893256.RA-k1Elz2lt0362TUiAaa09svgmBaQcYDgWV3RXei-Ayk130_provenance.
• NP247286.RAxJdv9s33dap4PdOpLDHMNk74FGigdWMuctNv1m0uChM130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247286.RAxJdv9s33dap4PdOpLDHMNk74FGigdWMuctNv1m0uChM130_provenance.
• NP247291.RAyliISc2uOUvbVZXygOTwRvuaU0nCD1F593u5VoUYh3Y130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247291.RAyliISc2uOUvbVZXygOTwRvuaU0nCD1F593u5VoUYh3Y130_provenance.
• NP247296.RA2XTMbhejRz00GSgP5eKFtB6hf5XzpksHG6XbZJuGBBA130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247296.RA2XTMbhejRz00GSgP5eKFtB6hf5XzpksHG6XbZJuGBBA130_provenance.